Company

Baker Heart & Diabetes Institute

Investors

Every investor coverage indicates participated in a round Baker Heart & Diabetes Institute raised.

Investor	Rounds	Invested
No investors recorded yet. Know one?

What Baker Heart & Diabetes Institute bought

Companies Baker Heart & Diabetes Institute acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Baker Heart & Diabetes Institute is not recorded as having acquired anything.

Coverage

Stories naming Baker Heart & Diabetes Institute. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

2 deals

MRFF awards $50 million to Australian team developing artificial heart

The federal MRFF has granted $50 million to the Artificial Heart Frontiers Program, a Monash-led consortium including BiVACOR, to advance a total artificial heart; the team earlier received $1 million in 2021.

@AuManufacturing 20 Feb 2024 Artificial Heart Frontiers Program Australian Government Baker Heart & Diabetes Institute BiVACOR Griffith University Monash University Queensland University of Technology St Vincent's The Alfred University of New South Wales University of Queensland University of Sydney US Food and Drug Administration Medical Research Future Fund Dr Daniel Timms Mark Butler

Also @AuManufacturing

Grant $1m

Healthtech startup 23Strands is taking genomics mainstream to transform medicine

Profile of Sydney genomics startup 23Strands, covering its university and research collaborations, a $1 million grant, an NHMRC-backed project, and its 2020 UNSW Health10X accelerator background.

Startup Daily 6 Feb 2023 23Strands Australian Artificial Intelligence Institute Baker Heart & Diabetes Institute CAD Frontiers CSIRO National Health & Medical Research Council UNSW UTS Prof Gemma Figtree Jie Lu Mark Grosser

Something wrong? Tell us